CSI Market
Sign In | Register

Aardvark Therapeutics Inc (AARD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AARD Annual Balance Sheets →
This page allows investors to track Aardvark Therapeutics Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/AARD/balance-sheets
https://api.csimarket.com/api/v1/companies/AARD/fundamentals
https://api.csimarket.com/api/v1/companies/AARD/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent60.34
Short-term Investments, Total0.01
Cash & Short-term Investments60.00
Prepaid Expense And Other Assets Current4.39
Total Current Assets64.11
Other Assets, Noncurrent0.69
Operating Lease Right Of Use Asset0.27
Total Assets64.80
Liabilities
Accounts Payable, Current AC1.59
Accrued Liabilities, Current AC5.03
Other Liabilities, Current0.41
Total Current Liabilities7.03
Total Long-term Debt0.00
Other liabilities, Noncurrent0.16
Operating Lease Liability Current0.34
Operating Lease Liability Noncurrent-
Total Liabilities7.19
Stockholders' Equity
Additional Paid In Capital Common Stock228.69
Retained Earnings / Accumulated Deficit-171.08
Other Equity0.00
Common Stockholder's Equity57.61
Total Stockholder's Equity57.61
Liabilities & Stockholder's Equity64.80
4 historic quarters locked

Sign in to unlock the full Aardvark Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Aardvark Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-458957

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI